Invited commentary. New evidence regarding statins as antiinflammatory agents in the context of ECC.
Fromes
Yves
Y
Institut de Myologie - INSERM U582, Groupe Hospitalier Pitié-Salpêtrière, 47, Boulevard de l'Hôpital, Paris 75651 Cedex 13, France. y.fromes@myologie.chups.jussieu.fr
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D007249:Inflammation / Q000517:prevention & control*; D023421:Models, Animal; D051381:Rats; D019821:Simvastatin / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin